Bonjesta Side Effects

Generic name: doxylamine / pyridoxine

Medically reviewed by Drugs.com. Last updated on Feb 20, 2024.

Note: This document provides detailed information about Bonjesta Side Effects associated with doxylamine / pyridoxine. Some dosage forms listed on this page may not apply specifically to the brand name Bonjesta.

Applies to doxylamine / pyridoxine: oral tablet delayed release, oral tablet extended release.

Common side effects of Bonjesta

Some side effects of doxylamine / pyridoxine may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Serious side effects of Bonjesta

Along with its needed effects, doxylamine/pyridoxine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking doxylamine / pyridoxine:

Get emergency help immediately if any of the following symptoms of overdose occur while taking doxylamine / pyridoxine:

Symptoms of overdose

• dizziness or lightheadedness
• dry mouth
• enlarged pupils
• fast, pounding, or irregular heartbeat or pulse
• feeling of constant movement of self or surroundings
• mental confusion
• palpitations
• restlessness
• sensation of spinning
• sleepiness

For healthcare professionals

Applies to doxylamine / pyridoxine: oral delayed release tablet, oral tablet extended release.

General adverse events

The most commonly reported side effects were somnolence, dizziness, dry mouth, and fatigue.^[Ref]

Nervous system

• Very common (10% or more): Somnolence (up to 14.3%)
• Common (1% to 10%): Dizziness
• Postmarketing reports: Anticholinergic effects, blurred vision, diplopia, facial dyskinesia, faintness, headache, migraines, paresthesia, psychomotor hyperactivity, severe somnolence, tremors, vertigo^[Ref]

Severe somnolence occurred when this drug was coadministered with central nervous system depressants (e.g., alcohol).

Anticholinergic effects may be worsened and prolonged with the concomitant use of MAO inhibitors.

Blurred vision, facial dyskinesia, faintness, headache, paresthesia, tremors, and/or vertigo may occur as a result of anticholinergic effects associated with antihistamines.^[Ref]

Gastrointestinal

• Common (1% to 10%): Dry mouth
• Postmarketing reports: Abdominal distention, abdominal pain, constipation, diarrhea, dry throat^[Ref]

Dry mouth and dry throat occurred as a result of anticholinergic effects associated with antihistamines.^[Ref]

Other

• Common (1% to 10%): Fatigue
• Postmarketing reports: Acute labyrinthitis, malaise, tinnitus^[Ref]

Acute labyrinthitis and tinnitus may occur as a result of anticholinergic effects associated with antihistamines.^[Ref]

Psychiatric

• Postmarketing reports: Anxiety, disorientation, insomnia, irritability, nervousness, nightmares, toxic psychoses^[Ref]

Insomnia, irritability, nervousness, and/or toxic psychoses may occur as a result of anticholinergic effects associated with antihistamines.^[Ref]

Dermatologic

• Postmarketing reports: Hyperhidrosis, maculopapular rash, pruritus, rash, sweating^[Ref]

Sweating may occur as a result of anticholinergic effects associated with antihistamines.^[Ref]

Respiratory

• Postmarketing reports: Dry nose, dyspnea, nasal stuffiness, thickening of bronchial secretions, wheezing^[Ref]

Dry nose, nasal stuffiness, and thickening of bronchial secretions, and/or wheezing may occur as a result of anticholinergic effects associated with antihistamines.^[Ref]

Hematologic

• Postmarketing reports: Agranulocytosis, hemolytic anemia, leukopenia, pancytopenia, thrombocytopenia^[Ref]

Agranulocytosis, hemolytic anemia, leukopenia, pancytopenia, and/or thrombocytopenia was rarely reported in patients taking antihistamines.^[Ref]

Cardiovascular

• Postmarketing reports: Chest discomfort, chest tightness, palpitation, tachycardia^[Ref]

Chest tightness may occur as a result of anticholinergic effects associated with antihistamines.^[Ref]

Genitourinary

• Postmarketing reports: Dysuria, urinary retention^[Ref]

Dysuria and urinary retention may occur as a result of anticholinergic effects associated with antihistamines.^[Ref]

Metabolic

• Postmarketing reports: Increased appetite, weight gain^[Ref]

Increased appetite and/or weight gain occurred in patients taking antihistamines.^[Ref]

Ocular

• Postmarketing reports: Visual disturbances^[Ref]

Visual disturbances may occur as a result of anticholinergic effects associated with antihistamines.^[Ref]

Hypersensitivity

• Postmarketing reports: Hypersensitivity^[Ref]

Musculoskeletal

• Postmarketing reports: Chills^[Ref]

Chills may occur as a result of anticholinergic effects associated with antihistamines.^[Ref]

Endocrine

• Postmarketing reports: Early menses^[Ref]

Early menses may occur as a result of anticholinergic effects associated with antihistamines.^[Ref]

See also:

Further information

Bonjesta side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.

Medical Disclaimer